• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人心房颤动的卒中预防:现有知识空白和创新领域:美国衰老研究联合会研讨会总结。

Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar.

机构信息

Cardiac Arrhythmia Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Geriatr Soc. 2013 Oct;61(10):1798-803. doi: 10.1111/jgs.12456. Epub 2013 Sep 19.

DOI:10.1111/jgs.12456
PMID:24083473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3801265/
Abstract

Atrial fibrillation (AF) is a common and morbid cardiac arrhythmia that increases in prevalence with advancing age. The risk of ischemic stroke, a primary and disabling hazard of AF, also increases with advancing age. The aging of the population is anticipated to contribute to a rising burden of AF-related morbidity and economic costs, given the close association between the arrhythmia and aging. Recent biological, diagnostic, and therapeutic developments raise hope that AF-related stroke can be largely prevented, yet despite advances in stroke prevention for individuals with AF, numerous scientific and clinical knowledge gaps remain, particularly as these developments are applied to older adults. Given the public health importance of AF-related stroke in elderly adults, a group of clinician-investigators convened on April 5, 2012, to identify promising areas for investigation that may ultimately reduce stroke-related morbidity. This article summarizes the meeting discussion and emphasizes innovative topic areas that may ultimately facilitate the application of novel preventive, diagnostic, and therapeutic insights into the management of older adults with AF. The opinions of those that participated in the meeting limit this report, which may not represent all of the questions that other experts in this field might raise.

摘要

心房颤动(AF)是一种常见且严重的心律失常,其发病率随年龄增长而增加。随着年龄的增长,AF 引起的缺血性中风的风险也会增加,而中风是 AF 的主要致残危险因素。鉴于心律失常与衰老之间存在密切关联,预计人口老龄化将导致与 AF 相关的发病率和经济成本负担增加。最近在生物学、诊断和治疗方面的进展带来了希望,即可以在很大程度上预防 AF 相关的中风,但尽管在预防 AF 个体的中风方面取得了进展,仍然存在许多科学和临床知识空白,尤其是在将这些进展应用于老年人时。鉴于 AF 相关中风对老年人的公共卫生重要性,一组临床研究人员于 2012 年 4 月 5 日召开会议,确定了有希望的研究领域,这些领域可能最终会降低中风相关的发病率。本文总结了会议讨论,并强调了创新的主题领域,这些领域最终可能有助于将新型预防、诊断和治疗方法应用于管理老年 AF 患者。参加会议的人员的意见局限了本报告,本报告可能无法代表该领域其他专家可能提出的所有问题。

相似文献

1
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar.老年人心房颤动的卒中预防:现有知识空白和创新领域:美国衰老研究联合会研讨会总结。
J Am Geriatr Soc. 2013 Oct;61(10):1798-803. doi: 10.1111/jgs.12456. Epub 2013 Sep 19.
2
[Epidemiology, clinical picture and management of atrial fibrillation].[心房颤动的流行病学、临床表现及管理]
Nervenarzt. 2011 Feb;82(2):159-60, 162-5. doi: 10.1007/s00115-010-3111-8.
3
Evidenced-based pharmacotherapy for rate control in atrial fibrillation.基于证据的心房颤动心率控制药物治疗。
Crit Care Nurs Q. 2013 Apr-Jun;36(2):237-43. doi: 10.1097/CNQ.0b013e31828415dc.
4
Treatment of atrial fibrillation.心房颤动的治疗。
Br Med Bull. 2008;88(1):75-94. doi: 10.1093/bmb/ldn046. Epub 2008 Dec 5.
5
[Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?].
Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S55-8. doi: 10.1055/s-0030-1249210. Epub 2010 Mar 10.
6
Atrial fibrillation in the elderly.老年人心房颤动。
Drugs Aging. 2013 Aug;30(8):593-601. doi: 10.1007/s40266-013-0094-8.
7
A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.心房颤动卒中预防的新局面:关注新型抗凝药物、抗心律失常药物和器械。
Stroke. 2011 Nov;42(11):3316-22. doi: 10.1161/STROKEAHA.111.617886. Epub 2011 Oct 13.
8
HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.HRS/NSA 2014 心房颤动和卒中调查:知识和观点方面的差距,改进的机会。
Heart Rhythm. 2015 Aug;12(8):e105-13. doi: 10.1016/j.hrthm.2015.04.039. Epub 2015 May 14.
9
Anticoagulation: stroke prevention in patients with atrial fibrillation.抗凝治疗:心房颤动患者的卒中预防
Cardiol Clin. 2009 Feb;27(1):125-35, ix. doi: 10.1016/j.ccl.2008.09.002.
10
Stroke prevention in atrial fibrillation patients.心房颤动患者的卒中预防。
Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819.

引用本文的文献

1
Impact of Frailty on Healthcare Outcomes after Cardioembolic Ischaemic Stroke Due to Atrial Fibrillation.因心房颤动导致的心源性栓塞性缺血性脑卒中后衰弱对医疗保健结局的影响。
Int J Environ Res Public Health. 2024 Feb 27;21(3):270. doi: 10.3390/ijerph21030270.
2
Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial.采用自由输血策略预防老年非心脏手术患者的死亡率及贫血相关缺血事件——LIBERAL试验的研究设计
Trials. 2019 Feb 4;20(1):101. doi: 10.1186/s13063-019-3200-3.
3
Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.

本文引用的文献

1
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.简单风险模型预测了一个种族和地理多样化人群中心房颤动的发生率:CHARGE-AF 联盟。
J Am Heart Assoc. 2013 Mar 18;2(2):e000102. doi: 10.1161/JAHA.112.000102.
2
National trends in oral anticoagulant use in the United States, 2007 to 2011.2007年至2011年美国口服抗凝剂使用的全国趋势。
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):615-21. doi: 10.1161/CIRCOUTCOMES.112.967299. Epub 2012 Sep 4.
3
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
用氟比他哌正电子发射断层扫描(Florbetapir-PET)诊断脑淀粉样血管病:一项前瞻性研究。
Neurology. 2016 Nov 8;87(19):2043-2049. doi: 10.1212/WNL.0000000000003197. Epub 2016 Sep 7.
4
Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis.口服抗凝剂与阿司匹林对房颤患者的疗效及安全性:一项荟萃分析。
Medicine (Baltimore). 2015 Jan;94(4):e409. doi: 10.1097/MD.0000000000000409.
5
The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects.美金刚治疗缺血性中风的二分法:剂量依赖性的保护和有害作用。
J Cereb Blood Flow Metab. 2015 Feb;35(2):230-9. doi: 10.1038/jcbfm.2014.188. Epub 2014 Nov 19.
6
Ectopy and expectations: can we predict atrial fibrillation, and should we try?异位心律与期望:我们能否预测房颤,又是否应该尝试?
Ann Intern Med. 2013 Dec 3;159(11):787-8. doi: 10.7326/0003-4819-159-11-201312030-00014.
7
Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?脑微出血和脑大出血:它们是否应该影响我们对抗栓治疗的建议?
Curr Cardiol Rep. 2013 Dec;15(12):425. doi: 10.1007/s11886-013-0425-8.
荟萃分析确定了六个心房颤动的新易感性位点。
Nat Genet. 2012 Apr 29;44(6):670-5. doi: 10.1038/ng.2261.
4
Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes.高龄患者心房颤动的导管消融治疗:安全性和结局。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):687-93. doi: 10.1111/j.1540-8167.2012.02293.x. Epub 2012 Apr 11.
5
Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.心房颤动卒中预防的进展:新型口服抗凝药的出现
Circulation. 2012 Mar 27;125(12):1577-83. doi: 10.1161/CIR.0b013e31825498e8.
6
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.阻断肾素-血管紧张素-醛固酮系统(RAAS)用于非瓣膜性心房颤动的一级预防:随机对照试验的系统评价和荟萃分析。
Int J Cardiol. 2013 Apr 30;165(1):17-24. doi: 10.1016/j.ijcard.2012.02.009. Epub 2012 Mar 14.
7
Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis.心房颤动导管消融术或抗心律失常药物治疗的健康结局:倾向匹配分析结果
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):171-81. doi: 10.1161/CIRCOUTCOMES.111.963108. Epub 2012 Feb 28.
8
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.全基因组关联研究鉴定出 HDAC9 中的一个变体与大动脉粥样硬化性缺血性卒中相关。
Nat Genet. 2012 Feb 5;44(3):328-33. doi: 10.1038/ng.1081.
9
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.《2012年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
10
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.